From combinatorial chemistry to cancer-targeting peptides

Molecular Pharmaceutics

Volumn 4, Issue 5, 2007, Pages 631-651

  Aina, Olulanu H ^a   Liu, Ruiwu ^a   Sutcliffe, Julie L ^b   Marik, Jan ^a   Pan, Chong Xian ^a   Lam, Kit S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

Cancer cell surface targeting agents; Combinatorial chemistry; Integrin; On bead cell binding; One bead one compound library; Optical imaging; Peptide library; PET imaging; Phage display

Indexed keywords

AMINO ACID DERIVATIVE; BOMBESIN; CELL SURFACE RECEPTOR; IBRITUMOMAB TIUXETAN; RITUXIMAB; SOMATOSTATIN; TOSITUMOMAB I 131;

B CELL LYMPHOMA; BREAST CANCER; CANCER CELL; COMBINATORIAL CHEMISTRY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; IN VIVO STUDY; LUNG CANCER; LYMPHOMA; NONHUMAN; OVARY CANCER; PHAGE DISPLAY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RETICULOENDOTHELIAL SYSTEM; REVIEW; T CELL LYMPHOMA;

ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, PROTEIN; HUMANS; LIGANDS; NEOPLASMS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY;

EID: 35548986989     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp700073y     Document Type: Review

References (151)

1. Kohler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256, 495-7.
2. Todorovska, A.; Roovers, R. C.; Dolezal, O.; Kortt, A. A.; Hoogenboom, H. R.; Hudson, P. J. Design and application of diabodies, triabodies and tetrabodies for cancer targeting. J. Immunol. Methods 2001, 248, 47-66.
3. Hudson, P. J.; Souriau, C. Engineered antibodies. Nat. Med 2003, 9, 129-34.
4. Capello, A.; Krenning, E. P.; Bernard, B. F.; Breeman, W. A.; van Hagen, M. P.; de Jong, M. Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog. J. Nucl. Med. 2004, 45, 1716-20.
5. Zhang, X.; Cai, W.; Cao, F.; Schreibmann, E.; Wu, Y.; Wu, J. C.; Xing, L.; Chen, X. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J. Nucl. Med. 2006, 47, 492-501.
6. Stewart, J. M.; Gera, L.; Chan, D. C.; York, E. J.; Simkeviciene, V.; Bunn, P. A.; Taraseviciene-Stewart, L. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Peptides 2005, 26, 1288-91.
7. Aina, O. H.; Sroka, T. C.; Chen, M. L.; Lam, K. S. Therapeutic cancer targeting peptides. Biopolymers 2002, 66, 184-199.
8. Geysen, H. M.; Meloen, R. H.; Barteling, S. J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. U.S.A 1984, 81, 3998-4002.
9. Scott, J. K.; Smith, G. P. Searching for peptide ligands with an epitope library. Science 1990, 249, 386-90.
10. Cwirla, S. E.; Peters, E. A.; Barrett, R. W.; Dower, W. J. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6378-82.
11. Devlin, J. J.; Panganiban, L. C.; Devlin, P. E. Random peptide libraries: a source of specific protein binding molecules. Science 1990, 249, 404-6.
12. Frank, R. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 1992, 48, 9217.
13. Fodor, S. P.; Read, I. L.; Pirrung, M. C.; Stryer, L.; Lu, A. T.; Solas, D. Light-directed, spatially addressable parallel chemical synthesis. Science 1991, 251, 767-73.
14. Houghten, R. A.; Pinilla, C; Blondelle, S. E.; Appel, J. R.; Dooley, C. T.; Cuervo, J. H. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991, 354, 84-6.
15. Brown, B. B.; Wagner, D. S.; Geysen, H. M. Using Electrospray Ionization Mass Spectrometry and a New Photolabile Linker - 3-Amino-3-(2-Nitrophenyl) Propionic Acid. Mol. Diversity 1995, 1, 4-12.
16. Songyang, Z.; Carraway, K. L.; Eck, M. J.; Harrison, S. C.; Feldman, R. A.; Mohammadi, M.; Schlessinger, J.; Hubbard, S. R.; Smith, D. P.; Eng, C.; Lorenzo, M. J.; Ponder, B. A. J.; Mayer, B. J.; Cantley, L. C. Catalytic Specificity of Protein-Tyrosine Kinases Is Critical for Selective Signalling. Nature 1995, 373, 536-539.
17. Lam, K. S.; Salmon, S. E.; Hersh, E. M.; Hruby, V. J.; Kazmierski, W. M.; Knapp, R. J. A New Type of Synthetic Peptide Library for Identifying Ligand-Binding Activity. Nature 1991, 354, 82-84.
18. Lam, K. S.; Lebl, M.; Krchnak, V. The 'one-bead-one-compound' combinatorial library method. Chem. Rev. 1997, 97, 411-448.
19. Winssinger, N.; Damoiseaux, R.; Tully, D. C.; Geierstanger, B. H.; Burdick, K.; Harris, J. L. PNA-encoded protease substrate microarrays. Chem. Biol. 2004, 11, 1351-60.
20. Liu, R.; Enstrom, A. M.; Lam, K. S. Combinatorial peptide library methods for immunobiology research. Exp. Hematol. 2003, 31, 11-30.
21. Rodi, D. J.; Mandava, S.; Makowski, L. In Drug Discovery Series/3: Phage Display in Biotechnology and Drug Discovery; Sachdev, S. S., Ed.; Taylor & Francis/CRC Press: Boca Raton, FL, 2005; pp 1-61.
22. Smith, G. P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228, 1315-7.
23. Frank, R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports - principles and applications. J. Immunol. Methods 2002, 267, 13-26.
24. Nicolaou, K. C.; Xiao, X. Y.; Parandoosh, Z.; Senyei, A.; Nova, M. P. Radiofrequency Encoded Combinatorial Chemistry. Angew. Chem., Int. Ed. 1995, 34, 2289-2291.
25. Moran, E. J.; Sarshar, S.; Cargill, J. F.; Shahbaz, M. M.; Lio, A.; Mjalli, A. M. M.; Armstrong, R. W. Radio Frequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide-Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase Ptp1b. J. Am. Chem. Soc. 1995, 117, 10787-10788.
26. Fodor, S. P. A.; Read, J. L.; Pirrung, M. C.; Stryer, L.; Lu, A. T.; Solas, D. Light-Directed, Spatially Addressable Parallel Chemical Synthesis. Science 1991, 251, 767-773.
27. Lam, K. S.; Renil, M. From combinatorial chemistry to chemical microarray. Curr. Opin. Chem. Biol 2002, 6, 353-358.
28. Geysen, H. M.; Rodda, S. J.; Mason, T. J. A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol. Immunol. 1986, 23, 709-15.
29. Dooley, C. T.; Houghten, R. A. The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. Life Sci. 1993, 52, 1509-17.
30. Deprez, B.; Williard, X.; Bourel, L.; Coste, H.; Hyafil, F.; Tartar, A.; Maia, H. L. S. Self-deciphering, orthogonal combinatorial libraries of soluble organic compounds: Discovery of a potent V2 vasopressin antagonist. Peptides 1994 1995, 455-456.
31. Erb, E.; Janda, K. D.; Brenner, S. Recursive deconvolution of combinatorial chemical libraries. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11422-6.
32. Fenniri, H.; Ding, L. H.; Ribbe, A. E.; Zyrianov, Y. Barcoded resins: A new concept for polymer-supported combinatorial library self-deconvolution. J. Am. Chem. Soc. 2001, 123, 8151-8152.
33. Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 1991, 37, 487-93.
34. Zuckermann, R. N.; Kerr, J. M.; Siani, M. A.; Banville, S. C.; Santi, D. V. Identification of Highest-Affinity Ligands by Affinity Selection from Equimolar Peptide Mixtures Generated by Robotic Synthesis. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 4505-4509.
35. Lam, K. S.; Liu, R.; Miyamoto, S.; Lehman, A. L.; Tuscano, J. M. Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. Acc. Chem. Res. 2003, 36, 370-377.
36. Meldal, M.; Svendsen, I.; Breddam, K.; Auzanneau, F. I. Portion-Mixing Peptide Libraries of Quenched Fluorogenic Substrates for Complete Subsite Mapping of Endoprotease Specificity. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3314-3318.
37. Meldal, M. The one-bead two-compound assay for solid phase screening of combinatorial libraries. Biopolymers 2002, 66, 93-100.
38. Olivos, H. J.; Bachhawat-Sikder, K.; Kodadek, T. Quantum dots as a visual aid for screening bead-bound combinatorial libraries. Chembiochem 2003, 4, 1242-5.
39. Juskowiak, G. L.; Stachel, S. J.; Tivitmahaisoon, P.; Van Vranken, D. L. Fluorogenic peptide sequences-transformation of short peptides into fluorophores under ambient photooxidative conditions. J. Am. Chem. Soc. 2004, 126, 550-6.
40. Salmon, S. E.; Liu-Stevens, R. H.; Zhao, Y.; Lebl, M.; Krchnak, V.; Wertman, K.; Sepetov, N.; Lam, K. S. High-volume cellular screening for anticancer agents with combinatorial chemical libraries: a new methodology. Mol. Diversity 1996, 2, 57-63.
41. Jayawickreme, C. K.; Sauls, H.; Bolio, N.; Ruan, J.; Moyer, M.; Burkhart, W.; Marron, B.; Rimele, T.; Shaffer, J. Use of a cell-based, lawn format assay to rapidly screen a 442,368 bead-based peptide library. J. Pharmacol. Toxicol. Methods 1999, 42, 189-97.
42. Silen, J. L.; Lu, A. T.; Solas, D. W.; Gore, M. A.; MacLean, D.; Shah, N. H.; Coffin, J. M.; Bhinderwala, N. S.; Wang, Y.; Tsutsui, K. T.; Look, G. C.; Campbell, D. A.; Hale, R. L.; Navre, M.; DeLuca-Flaherty, C. R. Screening for novel antimicrobials from encoded combinatorial libraries by using a two-dimensional agar format. Antimicrob. Agents Chemother 1998, 42, 1447-53.
43. Dennis, M. In Drug Discovery Series/3 "Phage Display in Biotechnology and Drug Discovery"; Sidhu, S. S., Ed.; Taylor & Francis (CRC press): Boca Raton, FL, 2005.
44. Kay, B. K.; Kasanov, J.; Yamabhai, M. Screening phage-displayed combinatorial peptide libraries. Methods 2001, 24, 240-6.
45. El-Mousawi, M.; Tchistiakova, L.; Yurchenko, L.; Pietrzynski, G.; Moreno, M.; Stanimirovic, D.; Ahmad, D.; Alakhov, V. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J. Biol. Chem. 2003, 278, 46681-91.
46. Ding, H.; Prodinger, W. M.; Kopecek, J. Identification of CD21-binding peptides with phage display and investigation of binding properties of HPMA copolymer-peptide conjugates. Bioconjugate Chem. 2006, 17, 514-23.
47. Czubayko, F.; Liaudet-Coopman, E. D.; Aigner, A.; Tuveson, A. T.; Berchem, G. J.; Wellstein, A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat. Med. 1997, 3, 1137-40.
48. Jouanneau, J.; Plouet, J.; Moens, G.; Thiery, J. P. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo. Oncogene 1997, 14, 671-6.
49. Bossard, C.; Van den Berghe, L.; Laurell, H.; Castano, C.; Cerutti, M.; Prats, A. C.; Prats, H. Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide. Cancer Res. 2004, 64, 7507-12.
50. Levin, E. G.; Sikora, L.; Ding, L.; Rao, S. P.; Sriramarao, P. Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. Am. J. Pathol. 2004, 164, 1183-90.
51. Cenni, E.; Perut, F.; Granchi, D.; Avnet, S.; Amato, I.; Brandi, M. L.; Giunti, A.; Baldini, N. Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res. 2007, 27, 315-9.
52. Ballinger, M. D.; Shyamala, V.; Forrest, L. D.; Deuter-Reinhard, M.; Doyle, L. V.; Wang, J. X.; Panganiban-Lustan, L.; Stratton, J. R.; Apell, G.; Winter, J. A.; Doyle, M. V.; Rosenberg, S.; Kavanaugh, W. M. Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. Nat. Biotechnol. 1999, 17, 1199-204.
53. McGuire, M. J.; Samli, K. N.; Chang, Y. C.; Brown, K. C. Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas. Exp. Hematol. 2006, 34, 443-52.
54. Kolonin, M. G.; Bover, L.; Sun, J.; Zurita, A. J.; Do, K. A.; Lahdenranta, J.; Cardo-Vila, M.; Giordano, R. J.; Jaalouk, D. E.; Ozawa, M. G.; Moya, C. A.; Souza, G. R.; Staquicini, F. I.; Kunyiasu, A.; Scudiero, D. A.; Holbeck, S. L.; Sausville, E. A.; Arap, W.; Pasqualini, R. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res. 2006, 66, 34-40.
55. Zitzmann, S.; Mier, W.; Schad, A.; Kinscherf, R.; Askoxylakis, V.; Kramer, S.; Altmann, A.; Eisenhut, M.; Haberkorn, U. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin. Cancer Res. 2005, 11, 139-46.
56. Samoylova, T. I.; Petrenko, V. A.; Morrison, N. E.; Globa, L. P.; Baker, H. J.; Cox, N. R. Phage probes for malignant glial cells. Mol. Cancer Ther. 2003, 2, 1129-37.
57. Lee, S. M.; Lee, E. J.; Hong, H. Y.; Kwon, M. K.; Kwon, T. H.; Choi, J. Y.; Park, R. W.; Kwon, T. G.; Yoo, E. S.; Yoon, G. S.; Kim, I. S.; Ruoslahti, E.; Lee, B. H. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol. Cancer Res. 2007, 5, 11-9.
58. Zhang, Y.; Chen, J.; Hu, Z.; Hu, D.; Pan, Y.; Ou, S.; Liu, G.; Yin, X.; Zhao, J.; Ren, L.; Wang, J. Panning and identification of a colon tumor binding peptide from a phage display peptide library. J. Biomol. Screening 2007, 12, 429-435.
59. Shukla, G. S.; Krag, D. N. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library. Oncol. Rep. 2005, 13, 757-64.
60. Oyama, T.; Sykes, K. F.; Samli, K. N.; Minna, J. D.; Johnston, S. A.; Brown, K. C. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett. 2003, 202, 219-30.
61. Zhou, X.; Chang, Y. C.; Oyama, T.; McGuire, M. J.; Brown, K. C. Cell-specific delivery of a chemotherapeutic to lung cancer cells. J. Am. Chem. Soc. 2004, 126, 15656-7.
62. Hoffman, J. A.; Giraudo, E.; Singh, M.; Zhang, L.; Inoue, M.; Porkka, K.; Hanahan, D.; Ruoslahti, E. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 2003, 4, 383-91.
63. Pasqualini, R. Vascular targeting with phage peptide libraries. Q. J. Nucl. Med. 1999, 43, 159-62.
64. Arap, W.; Pasqualini, R.; Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998, 279, 377-80.
65. Arap, W.; Haedicke, W.; Bernasconi, M.; Kain, R.; Rajotte, D.; Krajewski, S.; Ellerby, H. M.; Bredesen, D. E.; Pasqualini, R.; Ruoslahti, E. Targeting the prostate for destruction through a vascular address. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 1527-31.
66. Rajotte, D.; Arap, W.; Hagedorn, M.; Koivunen, E.; Pasqualini, R.; Ruoslahti, E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 1998, 102, 430-7.
67. Joyce, J. A.; Laakkonen, P.; Bernasconi, M.; Bergers, G.; Ruoslahti, E.; Hanahan, D. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 2003, 4, 393-403.
68. Bockmann, M.; Hilken, G.; Schmidt, A.; Cranston, A. N.; Tannapfel, A.; Drosten, M.; Frilling, A.; Ponder, B. A.; Putzer, B. M. Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection. Hum. Gene Ther. 2005, 16, 1267-75.
69. Kolonin, M. G.; Sun, J.; Do, K. A.; Vidal, C. I.; Ji, Y.; Baggerly, K. A.; Pasqualini, R.; Arap, W. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J. 2006, 20, 979-81.
70. Newton, J. R.; Kelly, K. A.; Mahmood, U.; Weissleder, R.; Deutscher, S. L. In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 2006, 8, 772-80.
71. Krag, D. N.; Shukla, G. S.; Shen, G. P.; Pero, S.; Ashikaga, T.; Fuller, S.; Weaver, D. L.; Burdette-Radoux, S.; Thomas, C. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 2006, 66, 7724-33.
72. Peng, L.; Liu, R.; Marik, J.; Wang, X.; Takada, Y.; Lam, K. S. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat. Chem. Biol. 2006, 2, 381-9.
73. Liu, R.; Marik, J.; Lam, K. S. A novel peptide-based encoding system for "one-bead one-compound" peptidomimetic and small molecule combinatorial libraries. J. Am. Chem. Soc. 2002, 124, 7678-80.
74. Wang, X.; Peng, L.; Liu, R.; Gill, S. S.; Lam, K. S. Partial alloc-deprotection approach for ladder synthesis of "one-bead one-compound" combinatorial libraries. J. Comb. Chem. 2005, 7, 197-209.
75. Song, A.; Zhang, J.; Lebrilla, C. B.; Lam, K. S. A novel and rapid encoding method based on mass spectrometry for "one-bead-one-compound" small molecule combinatorial libraries. J. Am. Chem. Soc. 2003, 125, 6180-8.
76. Wang, X.; Zhang, J.; Song, A.; Lebrilla, C. B.; Lam, K. S. Encoding method for OBOC small molecule libraries using a biphasic approach for ladder-synthesis of coding tags. J. Am. Chem. Soc. 2004, 126, 5740-9.
77. Chait, B. T.; Wang, R.; Beavis, R. C.; Kent, S. B. Protein ladder sequencing. Science 1993, 262, 89-92.
78. Youngquist, R. S.; Fuentes, G. R.; Lacey, M. P.; Keough, T. Generation and Screening of Combinatorial Peptide Libraries Designed for Rapid Sequencing by Mass Spectrometry. J. Am. Chem. Soc. 1995, 117, 3900-3906.
79. Wang, X.; Peng, L.; Liu, R.; Xu, B.; Lam, K. S. Applications of topologically segregated bilayer beads in 'one-bead one-compound' combinatorial libraries. J. Pept. Res. 2005, 65, 130-138.
80. DeRoock, I. B.; Pennington, M. E.; Sroka, T. C.; Lam, R. S.; Bowden, G. T.; Bair, E. L.; Cress, A. E. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. Cancer Res. 2001, 61, 3308-3313.
81. Sroka, T. C.; Marik, J.; Pennington, M. E.; Lam, K. S.; Cress, A. E. The minimum element of a synthetic peptide required to block prostate tumor cell migration. Cancer Biol. Ther. 2006, 5, 1556-1562.
82. Aina, O. H.; Marik, J.; Gandour-Edwards, R.; Lam, K. S. Near-Infrared Optical Imaging of Ovarian Cancer Xenografts with Novel alpha3-Integrin Binding Peptide "OA02". Mol. Imaging 2005, 4, 439-47.
83. Aina, O. H.; Marik, J.; Liu, R.; Lau, D. H.; Lam, K. S. Identification of novel targeting peptides for human ovarian cancer cells using "one-bead one-compound" combinatorial libraries. Mol. Cancer Ther. 2005, 4, 806-13.
84. Sivolapenko, G. B.; Skarlos, D.; Pectasides, D.; Stathopoulou, E.; Milonakis, A.; Sirmalis, G.; Stuttle, A.; Courtenay-Luck, N. S.; Konstantinides, K.; Epenetos, A. A. Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide. Eur. J. Nucl. Med. 1998, 25, 1383-9.
85. Becker, A.; Hessenius, C.; Licha, K.; Ebert, B.; Sukowski, U.; Semmler, W.; Wiedenmann, B.; Grotzinger, C. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat. Biotechnol. 2001, 19, 327-31.
86. Achilefu, S.; Bloch, S.; Markiewicz, M. A.; Zhong, T.; Ye, Y.; Dorshow, R. B.; Chance, B.; Liang, K. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 7976-81.
87. Chen, X.; Tohme, M.; Park, R.; Hou, Y.; Bading, J. R.; Conti, P. S. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol. Imaging 2004, 3, 96-104.
88. Haubner, R.; Wester, H. J.; Burkhart, F.; Senekowitsch-Schmidtke, R.; Weber, W.; Goodman, S. L.; Kessler, H.; Schwaiger, M. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med. 2001, 42, 326-36.
89. Liu, S.; Hsieh, W. Y.; Jiang, Y.; Kim, Y. S.; Sreerama, S. G.; Chen, X.; Jia, B.; Wang, F. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v) beta3-positive breast cancer. Bioconjugate Chem. 2007, 18, 438-46.
90. Chen, X.; Conti, P. S.; Moats, R. A. Cancer Res. 2004, 64, 8009-14.
91. Cheng, Z.; Wu, Y.; Xiong, Z.; Gambhir, S. S.; Chen, X. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjugate Chem. 2005, 16, 1433-41.
92. Hsu, A. R.; Hou, L. C.; Veeravagu, A.; Greve, J. M.; Vogel, H.; Tse, V.; Chen, X. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Mol. Imaging Biol. 2006, 8, 315-23.
93. Ye, Y.; Bloch, S.; Xu, B.; Achilefu, S. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J. Med. Chem. 2006, 49, 2268-75.
94. Gurfinkel, M.; Ke, S.; Wang, W.; Li, C.; Sevick-Muraca, E. M. Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging. J. Biomed. Opt. 2005, 10, 034019.
95. Bloch, S.; Xu, B.; Ye, Y.; Liang, K.; Nikiforovich, G. V.; Achilefu, S. Targeting Beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe. Mol. Pharmaceutics 2006, 3, 539-49.
96. Kelly, K.; Alencar, H.; Funovics, M.; Mahmood, U.; Weissleder, R. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res. 2004, 64, 6247-51.
97. Phelps, M. E. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9226-33.
98. Winnard, P.; Raman, V. Real time non-invasive imaging of receptor-ligand interactions in vivo. J Cell. Biochem. 2003, 90, 454-463.
99. Chen, X.; Hou, Y.; Tohme, M.; Park, R.; Khankaldyyan, V.; Gonzales-Gomez, I.; Bading, J. R.; Laug, W. E.; Conti, P. S. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J. Nucl. Med 2004, 45, 1776-83.
100. Chen, X.; Park, R.; Shahinian, A. H.; Tohme, M.; Khankaldyyan, V.; Bozorgzadeh, M. H.; Bading, J. R.; Moats, R.; Laug, W. E.; Conti, P. S. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol. 2004, 31, 179-89.
101. Chen, X.; Liu, S.; Hou, Y.; Tohme, M.; Park, R.; Bading, J. R.; Conti, P. S. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol. Imaging Biol 2004, 6, 350-9.
102. Chen, X.; Park, R.; Hou, Y.; Khankaldyyan, V.; Gonzales-Gomez, I.; Tohme, M.; Bading, J. R.; Laug, W. E.; Conti, P. S. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 1081-9.
103. Chen, X.; Park, R.; Tohme, M.; Shahinian, A. H.; Bading, J. R.; Conti, P. S. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjugate Chem. 2004, 15, 41-9.
104. Rogers, B. E.; Bigott, H. M.; McCarthy, D. W.; Della Manna, D.; Kim, J.; Sharp, T. L.; Welch, M. J. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a Cu-64-labeled bombesin analogue. Bioconjugate Chem. 2003, 14, 756-763.
105. Wester, H. J.; Schottelius, M.; Scheidhauer, K.; Meisetschlager, G.; Herz, M.; Rau, F. C.; Reubi, J. C.; Schwaiger, M. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel F-18-labelled, carbohydrated analogue of octreotide. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 117-122.
106. Yang, Y. S.; Zhang, X.; Xiong, Z.; Chen, X. Comparative in vitro and in vivo evaluation of two (64)Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nucl. Med. Biol. 2006, 33, 371-80.
107. Liu, S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol. Pharmaceutics 2006, 3, 472-87.
108. Song, A.; Wang, X.; Zhang, J.; Marik, J.; Lebrilla, C. B.; Lam, K. S. Synthesis of hydrophilic and flexible linkers for peptide derivatization in solid phase. Bioorg. Med. Chem. Lett 2004, 14, 161-5.
109. McCarthy, D. W.; Shefer, R. E.; Klinkowstein, R. E.; Bass, L. A.; Margeneau, W. H.; Cutler, C. S.; Anderson, C. J.; Welch, M. J. Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 1997, 24, 35-43.
110. Eskens, F. A.; Dumez, H.; Hoekstra, R.; Perschl, A.; Brindley, C.; Bottcher, S.; Wynendaele, W.; Drevs, J.; Verweij, J.; van Oosterom, A. T. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur. J. Cancer 2003, 39, 917-26.
111. Posey, J. A.; Khazaeli, M. B.; DelGrosso, A.; Saleh, M. N.; Lin, C. Y.; Huse, W.; LoBuglio, A. F. A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer. Cancer Biother. Radiopharm. 2001, 16, 125-32.
112. Curnis, F.; Sacchi, A.; Corti, A. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J. Clin. Invest. 2002, 110, 475-82.
113. Oku, N.; Asai, T.; Watanabe, K.; Kuromi, K.; Nagatsuka, M.; Kurohane, K.; Kikkawa, H.; Ogino, K.; Tanaka, M.; Ishikawa, D.; Tsukada, H.; Momose, M.; Nakayama, J.; Taki, T. Antineovascular therapy using novel peptides homing to angiogenic vessels. Oncogene 2002, 21, 2662-9.
114. Chen, X.; Plasencia, C.; Hou, Y.; Neamati, N. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J. Med. Chem 2005, 48, 1098-106.
115. Lee, T. Y.; Wu, H. C.; Tseng, Y. L.; Lin, C. T. A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery. Cancer Res. 2004, 64, 8002-8.
116. Fujioka, Y.; Arano, Y.; Ono, M.; Uehara, T.; Ogawa, K.; Namba, S.; Saga, T.; Nakamoto, Y.; Mukai, T.; Konishi, J.; Saji, H. Renal metabolism of 3′-iodohippuryl N-epsilon-maleoyl-L-lysine (HML)-conjugated Fab fragments. Bioconjugate Chem. 2001, 12, 178-185.
117. Kumaresan, P. R.; Natarajan, A.; Song, A.; Wang, X.; Liu, R.; DeNardo, G.; DeNardo, S.; Lam, K. S. Development of tissue plasminogen activator specific "on demand cleavable" (ode) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries. Bioconjugate Chem. 2007, 18, 175-82.
118. Samoylova, T. I.; Smith, B. F. Elucidation of muscle-binding peptides by phage display screening. Muscle Nerve 1999, 22, 460-6.
119. Wu, M.; Pasula, R.; Smith, P. A.; Martin, W. J., 2nd. 2nd Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther 2003, 10, 1429-36.
120. Eidne, K. A.; Henery, C. C.; Aitken, R. J. Selection of peptides targeting the human sperm surface using random peptide phage display identify ligands homologous to ZP3. Biol. Reprod 2000, 63, 1396-402.
121. Samoylova, T. I.; Ahmed, B. Y.; Vodyanoy, V.; Morrison, N. E.; Samoylov, A. M.; Globa, L. P.; Baker, H. J.; Cox, N. R. Targeting peptides for microglia identified via phage display. J Neuroimmunol. 2002, 127, 13-21.
122. Lee, L.; Buckley, C.; Blades, M. C.; Panayi, G.; George, A. J.; Pitzalis, C. Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum. 2002, 46, 2109-20.
123. Ardelt, P. U.; Wood, C. G.; Chen, L.; Mintz, P. J.; Moya, C.; Arap, M. A.; Wright, K. C.; Pasqualini, R.; Arap, W. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. J. Urol. 2003, 169, 1535-40.
124. Yao, V. J.; Ozawa, M. G.; Trepel, M.; Arap, W.; McDonald, D. M.; Pasqualini, R. Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. Am. J. Pathol. 2005, 166, 625-36.
125. McGuire, M. J.; Samli, K. N.; Johnston, S. A.; Brown, K. C. In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. J. Mol. Biol 2004, 342, 171-82.
126. Pilch, J.; Brown, D. M.; Komatsu, M.; Jarvinen, T. A.; Yang, M.; Peters, D.; Hoffman, R. M.; Ruoslahti, E. Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 2800-4.
127. Zhang, J.; Spring, H.; Schwab, M. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett 2001, 171, 153-64.
128. Askoxylakis, V.; Zitzmann, S.; Mier, W.; Graham, K.; Kramer, S.; von Wegner, F.; Fink, R. H.; Schwab, M.; Eisenhut, M.; Haberkorn, U. Preclinical evaluation of the breast cancer cell-binding peptide, p160. Clin. Cancer Res. 2005, 11, 6705-12.
129. Bockmann, M.; Drosten, M.; Putzer, B. M. Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma. J Gene Med. 2005, 7, 179-88.
130. Kelly, K. A.; Jones, D. A. Isolation of a colon tumor specific binding peptide using phage display selection. Neoplasia 2003, 5, 437-44.
131. Du, B.; Qian, M.; Zhou, Z.; Wang, P.; Wang, L.; Zhang, X.; Wu, M.; Zhang, P.; Mei, B. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem. Biophys. Res. Commun 2006, 342, 956-62.
132. Renschier, M. F.; Bhatt, R. R.; Dower, W. J.; Levy, R. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3623-7.
133. Romanov, V. I.; Durand, D. B.; Petrenko, V. A. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001, 47, 239-51.
134. Buhl, L.; Szecsi, P. B.; Gisselo, G. G.; Schafer-Nielsen, C. Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia. Br. J. Haematol. 2002, 116, 549-54.
135. Fukuda, M. N.; Ohyama, C.; Lowitz, K.; Matsuo, O.; Pasqualini, R.; Ruoslahti, E.; Fukuda, M. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res 2000, 60, 450-6.
136. Hong, F. D.; Clayman, G. L. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res. 2000, 60, 6551-6.
137. Koivunen, E.; Wang, B.; Ruoslahti, E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology 1995, 13, 265-70.
138. Koivunen, E.; Gay, D. A.; Ruoslahti, E. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem 1993, 268, 20205-10.
139. Murayama, O.; Nishida, H.; Sekiguchi, K. Novel peptide ligands for integrin alpha 6 beta 1 selected from a phage display library. J. Biochem. 1996, 120, 445-51.
140. Essler, M.; Ruoslahti, E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. U.S.A 2002, 99, 2252-7.
141. Pasqualini, R.; Koivunen, E.; Kain, R.; Lahdenranta, J.; Sakamoto, M.; Stryhn, A.; Ashmun, R. A.; Shapiro, L. H.; Arap, W.; Ruoslahti, E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer. Res. 2000, 60, 722-7.
142. Wu, P.; Leinonen, J.; Koivunen, E.; Lankinen, H.; Stenman, U. H. Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity. Eur. J. Biochem. 2000, 267, 6212-20.
143. Arap, W.; Kolonin, M. G.; Trepel, M.; Lahdenranta, J.; Cardo-Vila, M.; Giordano, R. J.; Mintz, P. J.; Ardelt, P. U.; Yao, V. J.; Vidal, C. I.; Chen, L.; Flamm, A.; Valtanen, H.; Weavind, L. M.; Hicks, M. E.; Pollock, R. E.; Botz, G. H.; Bucana, C. D.; Koivunen, E.; Cahill, D.; Troncoso, P.; Baggerly, K. A.; Pentz, R. D.; Do, K. A.; Logothetis, C. J.; Pasqualini, R. Steps toward mapping the human vasculature by phage display. Nat. Med. 2002, 8, 121-7.
144. Dubey, P. K.; Mishra, V.; Jain, S.; Mahor, S.; Vyas, S. P. Liposomes modified with cyclic RGD peptide for tumor targeting. J. Drug Target 2004, 12, 257-64.
145. Laakkonen, P.; Porkka, K.; Hoffman, J. A.; Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 2002, 8, 751-5.
146. Lam, K. S.; Lou, Q.; Zhao, Z. G.; Smith, J.; Chen, M. L.; Pleshko, E.; Salmon, S. E. diotype specific peptides bind to the surface immunoglobulins of two murine B-cell lymphoma lines, inducing signal transduction. Biomed Pept. Proteins Nucleic Acids 1995, 1, 205-210.
147. Lau, D.; Guo, L.; Liu, R.; Marik, J.; Lam, K. Peptide ligands targeting integrin alpha3beta1 in non-small cell lung cancer. Lung Cancer 2006, 52, 291-7.
148. Park, S. I.; Manat, R.; Vikstrom, B.; Amro, N.; Song, L. W.; Lam, K. S. The use of one-bead one-compound combinatorial library method to identify peptide ligands for alpha4-beta-1 integrin receptor in non-Hodgkin's lymphoma. Lett. Pept. Sci. 2002, 8, 171-178.
149. Liu, R.; Peng, L.; Han, H. J.; Lam, K. S. Structure-activity relationship studies of a series of peptidomimetic ligands for alpha(4)beta(1) integrin on Jurkat T-leukemia cells. Biopolymers 2006, 84, 595-604.
150. DeRoock, I. B.; Pennington, M. E.; Sroka, T. C.; Lam, K. S.; Bowden, G. T.; Bair, E. L.; Cress, A. E. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. Cancer Res. 2001, 1, 3308-3313.
151. Pennington, M. E.; Lam, K. S.; Cress, A. E. The use of a combinatorial library method to isolate human tumor cell adhesion peptides. Mol. Diversity 1996, 2, 19-28.